Lange U, Kürten B, Müller-Ladner U, Uhlemann C
Abteilung Rheumatologie, Klinische Immunologie, Physikalische Medizin und Osteologie, Kerckhoff-Klinik, Benekestrasse 2-8, Bad Nauheim, Germany.
Z Rheumatol. 2007 Dec;66(8):727-33. doi: 10.1007/s00393-007-0217-x.
Ankylosing spondylitis (AS) is one of the most common chronic inflammatory rheumatic diseases characterized by erosions and bone proliferation with consecutive morphologic and functional deficits. Physiotherapeutic and rehabilitation measures are often necessary for AS patients for their whole life. In recent years, biologicals have substantially improved the outcome in AS patients, but their positive influence on vertebral and joint functions still requires differential indicative physiotherapeutic strategies and rehabilitation, in most cases in combination with effective analgesic and anti-inflammatory medication. Although physical therapy and rehabilitation have not been investigated in large controlled trials, they are essential for the multimodal therapeutic concept of AS.
强直性脊柱炎（AS）是最常见的慢性炎症性风湿性疾病之一，其特征为侵蚀和骨质增生，并伴有连续的形态学和功能缺陷。对于AS患者来说，物理治疗和康复措施往往是终身必需的。近年来，生物制剂显著改善了AS患者的治疗效果，但它们对脊柱和关节功能的积极影响仍需要差异化的针对性物理治疗策略和康复措施，在大多数情况下还需结合有效的止痛和抗炎药物。尽管物理治疗和康复尚未在大型对照试验中进行研究，但它们对于AS的多模式治疗理念至关重要。
